Azala

Mexico Pharmaceuticals Report - November 2025

Gorde:
Argitaratua izan da:Fitch Solutions Country Industry Reports (Nov 7, 2025), p. 1-56
Argitaratua:
Fitch Solutions Group Limited
Gaiak:
Mexico
Pharmaceuticals
Statistical data
Industrywide conditions
Market analysis
Industry analysis
Business forecasts
SWOT analysis
Pharmaceutical industry
Sarrera elektronikoa:Citation/Abstract
Full Text - PDF
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Laburpena:Mexico’s pharma sector is poised to expand despite persistent hurdles around procurement and patent protection. Demand for cutting-edge therapies targeting chronic conditions is climbing, and as Latin America’s second-largest market, Mexico offers sizable openings for firms developing innovative medicines. That said, relatively low per-capita drug spending could limit widespread adoption of branded, patented products, likely boosting the role of generics. At the same time, government initiatives to bolster domestic manufacturing are expected to spur more cross-border partnerships, with a particular focus on technology transfer.
ISSN:2976-4750
Baliabidea:ABI/INFORM Trade & Industry